

A foreign shareholder is prevented from exercising pre-emption rights during a Turkish company’s capital increase. Learn about dilution, restriction of subscription rights, shareholder resolutions, injunctions, annulment actions and compensation claims.
A capital increase can significantly alter the ownership structure of a Turkish company. For a foreign shareholder, one of the most serious risks arises when new shares are issued but the shareholder is prevented from exercising the right to participate proportionately. The result may be substantial shareholding dilution, reduced voting power, loss of dividend participation and, in some cases, loss of influence or control over the company. Under Turkish company law, existing shareholders generally benefit from rights designed to preserve their proportional participation in a capital increase, subject to statutory conditions and legally permissible restrictions. If a foreign shareholder is excluded improperly, immediate action may be necessary because waiting until the capital increase has been completed and new shares have been allocated can make the commercial dispute substantially more difficult.
A pre-emption or subscription right in the capital-increase context generally allows an existing shareholder to acquire newly issued shares in proportion to the shareholder’s existing participation.
For example, if an investor owns 30% of a company before an ordinary proportional capital increase, exercising the corresponding subscription right can ordinarily help the investor preserve that percentage.
Dilution affects much more than the nominal number of shares held by an investor. A reduced percentage can affect voting rights, dividend entitlement, board influence, minority rights and contractual protections that depend on maintaining a particular ownership threshold.
A foreign investor should therefore treat interference with subscription rights as a potentially significant corporate-control issue.
Disputes can arise where the shareholder is not properly informed of the capital increase, is given insufficient time to participate, receives incorrect payment instructions, is told that only certain shareholders may subscribe, or discovers that new shares have already been allocated to the majority shareholder or another investor.
Another possibility is that the company formally restricts or removes subscription rights.
These situations require different legal analyses.
Foreign nationality alone does not ordinarily provide a general basis for preventing a shareholder from participating in a capital increase.
Any restriction should be examined according to Turkish company law, the company’s articles of association, the relevant corporate resolutions and any applicable shareholders’ agreement.
The foreign shareholder should immediately obtain the corporate documentation relating to the transaction. Relevant materials can include the shareholders’ meeting or board resolutions, capital-increase documentation, amended articles, notices, subscription procedures, payment records and commercial registry documentation.
The investor should determine exactly how the increase was structured.
This is one of the first questions to answer.
There is a substantial difference between a company formally adopting a decision restricting existing shareholders’ subscription rights and management simply refusing to allow one particular shareholder to participate.
The legal defense should identify which situation actually occurred.
A majority shareholder should not assume that control of the voting majority creates an unrestricted power to dilute minority shareholders.
Where subscription rights are restricted, the statutory conditions, required corporate decision and legitimate justification should be examined carefully.
A capital increase should not simply become a mechanism for transferring economic value or corporate control from a minority shareholder to the majority.
Where the transaction appears designed primarily to dilute a particular shareholder, the purpose, timing, pricing and allocation of the new shares can become important evidence.
The company may genuinely need additional capital for expansion, debt repayment, regulatory requirements, investment or working capital.
A legitimate need for capital, however, does not automatically justify excluding one shareholder from participating.
The necessity of the increase and the necessity of any restriction should be considered separately.
Notice is frequently central to these disputes.
Determine what notice was required, how it was delivered, when the shareholder actually received it and whether the shareholder had a meaningful opportunity to exercise the right.
International shareholders frequently communicate with Turkish companies electronically or through representatives.
If the company deliberately sends notice to an obsolete address despite knowing the shareholder’s current contact information, preserve evidence demonstrating the company’s actual knowledge.
The shareholder should identify the legally applicable and company-specific period for exercising subscription rights.
Do not rely on informal statements from company management. Obtain the relevant corporate decision and official documentation immediately.
If the investor was ready and willing to subscribe, document this fact.
Relevant evidence may include emails requesting bank details, written subscription requests, proof of available funds, attempted transfers and correspondence with directors or other shareholders.
This can become particularly important if the company later argues that the investor voluntarily declined participation.
Do not simply allow the deadline to expire.
The investor should document the attempted performance, request written payment instructions and consider the appropriate legal mechanism for protecting the right before the capital increase is completed.
Foreign investors can encounter compliance checks or international transfer delays.
If the shareholder initiated payment within the relevant period but banking procedures delayed receipt, preserve SWIFT records, payment instructions and correspondence with the bank and company.
The company’s articles can contain important provisions concerning capital, share classes, privileges and corporate procedures.
The shareholder should compare the challenged transaction with both statutory rules and the articles.
Foreign investors frequently have contractual protections exceeding statutory minimum rights.
The shareholders’ agreement may contain anti-dilution provisions, reserved matters, consent rights, funding procedures, pre-emption mechanisms, valuation protections or requirements for unanimous approval.
A breach may therefore generate both corporate-law and contractual remedies.
A shareholders’ agreement can create contractual obligations between the parties without automatically determining the validity of every corporate resolution.
The investor should therefore evaluate corporate remedies and contractual claims separately.
If the company has privileged or different classes of shares, determine whether the capital increase affects those rights differently.
A transaction that disproportionately alters the position of a particular share class may require additional analysis.
Warning signs may include a sudden capital increase without clear commercial necessity, exclusion of only one shareholder, allocation of all new shares to the controlling shareholder, unusually short notice, refusal to provide payment instructions or a transaction occurring immediately after a shareholder dispute.
No single fact automatically proves abuse, but the complete sequence should be documented.
Where new shares are issued in circumstances that transfer significant economic value, the financial terms should be reviewed.
An investor facing dilution should examine the company’s valuation, financial statements, capital need and economic effect of the issuance.
Once a dispute emerges, obtain current information showing the ownership structure before and after the transaction.
This helps establish the actual dilution and identify the recipients of newly issued shares.
Potentially. Depending on the company type, decision involved, legal defect and procedural circumstances, an action seeking annulment or another form of judicial review may be available.
Corporate litigation deadlines can be strict, so the date and nature of the relevant resolution should be identified immediately.
The investor should not spend months negotiating informally while procedural deadlines continue running.
Commercial negotiations can continue alongside preservation of formal legal rights.
Where implementation of the capital increase threatens to create difficult-to-reverse consequences, interim judicial protection may become important.
The appropriate relief depends on the specific corporate action, evidence and procedural posture.
Once new shares have been issued, registered and incorporated into subsequent corporate decisions, reversing the practical consequences may become more complicated.
Early intervention can therefore be critical in a serious dilution dispute.
A completed or registered capital increase does not automatically mean that an excluded shareholder has no legal options.
The available remedies depend on the defect, timing, company type and corporate decisions involved.
Potentially, where the statutory requirements for challenging the relevant corporate resolution are satisfied.
The precise cause of action should be determined from the corporate documents rather than assuming that every dilution dispute requires the same lawsuit.
Some exceptionally serious defects may raise questions beyond ordinary annulment.
The distinction can have important procedural consequences and should be analyzed according to the particular resolution and violation.
If directors or managers participate in an unlawful capital increase or intentionally interfere with a shareholder’s rights, potential management liability should be considered separately.
Personal liability is not automatic merely because an individual serves as a director; the specific conduct, breach, loss and causation must be analyzed.
Where a controlling shareholder uses corporate power in a manner that allegedly violates statutory or contractual obligations, claims against that shareholder may also need to be evaluated.
This is particularly important where the capital increase forms part of a broader shareholder conflict.
Potentially. If unlawful conduct causes a measurable financial loss, compensation claims may arise depending on the legal basis and defendants involved.
The investor should preserve valuation evidence showing the economic effect of the dilution.
Do not describe the damage merely as “my shares were diluted.”
Calculate the percentage before and after the capital increase, voting-power change, value transferred through the issuance and any threshold rights lost.
A reduction in percentage may cause the investor to fall below a threshold necessary to exercise particular minority or governance rights.
That consequence should be identified explicitly when assessing urgency and damages.
If a shareholders’ agreement or corporate structure links board nomination rights to a minimum shareholding percentage, dilution can affect management participation as well.
The contractual consequences should therefore be examined together with the statutory corporate consequences.
Emails, messages, meeting minutes and presentations can reveal why the capital increase was proposed and how management intended to allocate the new shares.
Preserve these records before access to company systems becomes restricted.
The commercial justification for the capital increase may be tested against the company’s financial position.
Cash-flow statements, budgets, financing alternatives and board materials can become relevant where the necessity of the transaction is disputed.
A foreign shareholder may be asked to sign documents confirming non-participation, consent or waiver of subscription rights.
Such documents should be reviewed carefully before signature.
If a local representative attended the meeting, determine precisely what authority was granted and whether the representative consented to any restriction.
Unauthorized or disputed representation can create a separate issue.
Act immediately.
Obtain the corporate resolutions, registration records, notices and shareholder structure and determine when the investor legally and factually became aware of the transaction.
The timing can affect available remedies.
Identify the recipient and the legal basis of the allocation.
The analysis may differ depending on whether the new shares went to the majority shareholder, an affiliate, an employee, a strategic investor or an unrelated third party.
Sometimes dilution occurs alongside an attempt to change control, remove management, force a minority exit or restructure the company.
The investor should evaluate the entire sequence rather than treating the capital increase as an isolated event.
The articles of association, shareholders’ agreement, investment agreement, share-purchase agreement and later amendments may contain interconnected protections.
Reading only one document can miss important remedies.
Many foreign-investment agreements contain arbitration provisions.
Corporate-law claims concerning Turkish corporate resolutions and contractual claims under a shareholders’ agreement may raise different jurisdictional questions. The dispute-resolution architecture should therefore be mapped before proceedings begin.
Foreign investors often hold relevant emails, payment records, board correspondence and investment documents outside Turkey.
Create a complete evidence file immediately rather than waiting for litigation.
A foreign shareholder prevented from exercising pre-emption rights should immediately obtain the capital-increase resolutions and registration documents, calculate the dilution, determine whether subscription rights were formally restricted, verify notice and exercise periods, document attempts to subscribe and pay, review the articles and shareholders’ agreement, identify newly allocated shares and recipients, preserve communications, evaluate interim judicial protection and protect all applicable corporate-litigation deadlines.
Foreign nationality alone does not ordinarily provide a general basis for exclusion. The applicable corporate rules and any formal restriction of subscription rights must be examined.
Potentially, subject to the requirements applicable to the company and capital increase. A majority shareholder should not assume unrestricted power to eliminate minority participation.
The notification process, corporate records and timing should be examined immediately. Improper notice can become an important part of the challenge.
The shareholder should document every attempt to subscribe and request payment instructions in writing rather than allowing the exercise period to expire silently.
Depending on the facts and procedural requirements, urgent judicial protection may potentially be considered.
Potentially. Registration or completion does not automatically eliminate every corporate or contractual remedy.
Potentially, where an actionable violation caused measurable financial loss. Valuation and causation evidence will be important.
It may. Many investment agreements contain anti-dilution, consent, reserved-matter or funding provisions that should be reviewed separately from statutory rights.
Potentially in appropriate circumstances, but liability is not automatic. The specific breach, conduct, damage and causal connection must be established.
Obtain the capital-increase documents immediately, calculate the exact dilution and determine whether the shareholder’s subscription rights were formally restricted or were simply obstructed in practice. At the same time, protect any applicable litigation deadline and evaluate whether urgent interim protection is necessary before the new ownership structure becomes more difficult to reverse.
Capital increases can become major shareholder disputes when they involve pre-emption rights, dilution, majority abuse, exclusion from subscription, loss of voting power, board-control changes, shareholder agreements, injunctions and corporate litigation. Fırat Fesih Kaya Law Office assists foreign shareholders, international investors and foreign-owned companies in Turkish corporate disputes involving capital increases and shareholder rights. Lawyer Fırat Fesih Kaya provides legal assistance in reviewing capital-increase resolutions, protecting subscription rights, seeking urgent judicial measures, challenging disputed corporate decisions, enforcing shareholders’ agreements and pursuing compensation claims arising from unlawful dilution.
Phone: +90 312 434 22 22
Mobile: +90 532 769 22 22
Email: info@firatfesihkaya.av.tr
Address: Mevlana Boulevard No:221, Yıldırım Tower, Office No:148, 06520 Balgat, Çankaya, Ankara, Turkey